Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression

Jonathan A. Fridell, Avinash Agarwal, John A. Powelson, William C. Goggins, Martin Milgrom, Mark D. Pescovitz, A. Joseph Tector

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Steroid withdrawal from patients taking prednisone for their renal allograft at the time of reinduction of immunosuppression for subsequent pancreas after kidney (PAK) transplantation has not been explored. Our expectation was that lymphocyte depletion, in conjunction with an augmentation of immunosuppression at the time of pancreas transplantation would protect the recipient from rejection of the renal allograft when chronic maintenance steroids are withdrawn. METHODS. Pancreas transplantation was performed using systemic venous drainage and enteric exocrine drainage. Regardless of preoperative immunosuppression, all patients received induction with antithymocyte globulin, a brief taper of intravenous solumedrol over four to five days, maintenance therapy with tacrolimus and sirolimus and either resumption of chronic maintenance steroids or complete withdrawal of steroids. RESULTS. A total of 30 PAK transplants were performed in 29 recipients and divided into two groups: continuation of chronic steroids (n=10) or steroid-free (n=19). One pancreas allograft was lost and there was a single mortality in the steroid free group. There was no significant difference in renal function or incidence of infections. CONCLUSION. Steroids can be safely withdrawn following pancreas after kidney transplantation for recipients already on maintenance prednisone in the setting of rabbit antithymocyte globulin induction and tacrolimus and sirolimus maintenance immunosuppression.

Original languageEnglish
Pages (from-to)389-392
Number of pages4
JournalTransplantation
Volume82
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Prednisone
Kidney Transplantation
Immunosuppression
Pancreas
Steroids
Maintenance
Allografts
Kidney
Pancreas Transplantation
Antilymphocyte Serum
Tacrolimus
Sirolimus
Drainage
Methylprednisolone Hemisuccinate
Lymphocyte Depletion
Rabbits
Transplants
Mortality
Incidence
Infection

Keywords

  • Pancreas transplantation
  • Renal transplantation
  • Steroid withdrawal

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Fridell, J. A., Agarwal, A., Powelson, J. A., Goggins, W. C., Milgrom, M., Pescovitz, M. D., & Tector, A. J. (2006). Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation, 82(3), 389-392. https://doi.org/10.1097/01.tp.0000228904.01482.88

Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. / Fridell, Jonathan A.; Agarwal, Avinash; Powelson, John A.; Goggins, William C.; Milgrom, Martin; Pescovitz, Mark D.; Tector, A. Joseph.

In: Transplantation, Vol. 82, No. 3, 2006, p. 389-392.

Research output: Contribution to journalArticle

Fridell, JA, Agarwal, A, Powelson, JA, Goggins, WC, Milgrom, M, Pescovitz, MD & Tector, AJ 2006, 'Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression', Transplantation, vol. 82, no. 3, pp. 389-392. https://doi.org/10.1097/01.tp.0000228904.01482.88
Fridell, Jonathan A. ; Agarwal, Avinash ; Powelson, John A. ; Goggins, William C. ; Milgrom, Martin ; Pescovitz, Mark D. ; Tector, A. Joseph. / Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. In: Transplantation. 2006 ; Vol. 82, No. 3. pp. 389-392.
@article{c19dd2d714894f74b3d03b4a85c9d8c2,
title = "Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression",
abstract = "Steroid withdrawal from patients taking prednisone for their renal allograft at the time of reinduction of immunosuppression for subsequent pancreas after kidney (PAK) transplantation has not been explored. Our expectation was that lymphocyte depletion, in conjunction with an augmentation of immunosuppression at the time of pancreas transplantation would protect the recipient from rejection of the renal allograft when chronic maintenance steroids are withdrawn. METHODS. Pancreas transplantation was performed using systemic venous drainage and enteric exocrine drainage. Regardless of preoperative immunosuppression, all patients received induction with antithymocyte globulin, a brief taper of intravenous solumedrol over four to five days, maintenance therapy with tacrolimus and sirolimus and either resumption of chronic maintenance steroids or complete withdrawal of steroids. RESULTS. A total of 30 PAK transplants were performed in 29 recipients and divided into two groups: continuation of chronic steroids (n=10) or steroid-free (n=19). One pancreas allograft was lost and there was a single mortality in the steroid free group. There was no significant difference in renal function or incidence of infections. CONCLUSION. Steroids can be safely withdrawn following pancreas after kidney transplantation for recipients already on maintenance prednisone in the setting of rabbit antithymocyte globulin induction and tacrolimus and sirolimus maintenance immunosuppression.",
keywords = "Pancreas transplantation, Renal transplantation, Steroid withdrawal",
author = "Fridell, {Jonathan A.} and Avinash Agarwal and Powelson, {John A.} and Goggins, {William C.} and Martin Milgrom and Pescovitz, {Mark D.} and Tector, {A. Joseph}",
year = "2006",
doi = "10.1097/01.tp.0000228904.01482.88",
language = "English",
volume = "82",
pages = "389--392",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression

AU - Fridell, Jonathan A.

AU - Agarwal, Avinash

AU - Powelson, John A.

AU - Goggins, William C.

AU - Milgrom, Martin

AU - Pescovitz, Mark D.

AU - Tector, A. Joseph

PY - 2006

Y1 - 2006

N2 - Steroid withdrawal from patients taking prednisone for their renal allograft at the time of reinduction of immunosuppression for subsequent pancreas after kidney (PAK) transplantation has not been explored. Our expectation was that lymphocyte depletion, in conjunction with an augmentation of immunosuppression at the time of pancreas transplantation would protect the recipient from rejection of the renal allograft when chronic maintenance steroids are withdrawn. METHODS. Pancreas transplantation was performed using systemic venous drainage and enteric exocrine drainage. Regardless of preoperative immunosuppression, all patients received induction with antithymocyte globulin, a brief taper of intravenous solumedrol over four to five days, maintenance therapy with tacrolimus and sirolimus and either resumption of chronic maintenance steroids or complete withdrawal of steroids. RESULTS. A total of 30 PAK transplants were performed in 29 recipients and divided into two groups: continuation of chronic steroids (n=10) or steroid-free (n=19). One pancreas allograft was lost and there was a single mortality in the steroid free group. There was no significant difference in renal function or incidence of infections. CONCLUSION. Steroids can be safely withdrawn following pancreas after kidney transplantation for recipients already on maintenance prednisone in the setting of rabbit antithymocyte globulin induction and tacrolimus and sirolimus maintenance immunosuppression.

AB - Steroid withdrawal from patients taking prednisone for their renal allograft at the time of reinduction of immunosuppression for subsequent pancreas after kidney (PAK) transplantation has not been explored. Our expectation was that lymphocyte depletion, in conjunction with an augmentation of immunosuppression at the time of pancreas transplantation would protect the recipient from rejection of the renal allograft when chronic maintenance steroids are withdrawn. METHODS. Pancreas transplantation was performed using systemic venous drainage and enteric exocrine drainage. Regardless of preoperative immunosuppression, all patients received induction with antithymocyte globulin, a brief taper of intravenous solumedrol over four to five days, maintenance therapy with tacrolimus and sirolimus and either resumption of chronic maintenance steroids or complete withdrawal of steroids. RESULTS. A total of 30 PAK transplants were performed in 29 recipients and divided into two groups: continuation of chronic steroids (n=10) or steroid-free (n=19). One pancreas allograft was lost and there was a single mortality in the steroid free group. There was no significant difference in renal function or incidence of infections. CONCLUSION. Steroids can be safely withdrawn following pancreas after kidney transplantation for recipients already on maintenance prednisone in the setting of rabbit antithymocyte globulin induction and tacrolimus and sirolimus maintenance immunosuppression.

KW - Pancreas transplantation

KW - Renal transplantation

KW - Steroid withdrawal

UR - http://www.scopus.com/inward/record.url?scp=33747091276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747091276&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000228904.01482.88

DO - 10.1097/01.tp.0000228904.01482.88

M3 - Article

C2 - 16906038

AN - SCOPUS:33747091276

VL - 82

SP - 389

EP - 392

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -